JP2004502454A - ヒト骨髄腫細胞系 - Google Patents

ヒト骨髄腫細胞系 Download PDF

Info

Publication number
JP2004502454A
JP2004502454A JP2002509461A JP2002509461A JP2004502454A JP 2004502454 A JP2004502454 A JP 2004502454A JP 2002509461 A JP2002509461 A JP 2002509461A JP 2002509461 A JP2002509461 A JP 2002509461A JP 2004502454 A JP2004502454 A JP 2004502454A
Authority
JP
Japan
Prior art keywords
human
cells
cell line
producing
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002509461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502454A5 (enExample
Inventor
カーパス，エイブラハム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Publication of JP2004502454A publication Critical patent/JP2004502454A/ja
Publication of JP2004502454A5 publication Critical patent/JP2004502454A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2002509461A 2000-07-07 2001-07-09 ヒト骨髄腫細胞系 Withdrawn JP2004502454A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (2)

Publication Number Publication Date
JP2004502454A true JP2004502454A (ja) 2004-01-29
JP2004502454A5 JP2004502454A5 (enExample) 2008-07-31

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509461A Withdrawn JP2004502454A (ja) 2000-07-07 2001-07-09 ヒト骨髄腫細胞系

Country Status (12)

Country Link
US (1) US7387873B2 (enExample)
EP (1) EP1299524B1 (enExample)
JP (1) JP2004502454A (enExample)
KR (1) KR20030022850A (enExample)
CN (1) CN100497601C (enExample)
AT (1) ATE440945T1 (enExample)
AU (2) AU6930001A (enExample)
CA (1) CA2415484A1 (enExample)
DE (1) DE60139694D1 (enExample)
IL (1) IL153641A0 (enExample)
NO (1) NO20030019L (enExample)
WO (1) WO2002004607A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주
US7491530B2 (en) 2001-12-18 2009-02-17 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) * 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115161311B (zh) * 2022-08-22 2025-05-06 广东忠信生物科技有限公司 高效筛选分泌单克隆抗体的杂交瘤细胞的方法及其应用
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주

Also Published As

Publication number Publication date
ATE440945T1 (de) 2009-09-15
AU2001269300B2 (en) 2006-06-22
WO2002004607A1 (en) 2002-01-17
KR20030022850A (ko) 2003-03-17
US20040023339A1 (en) 2004-02-05
AU6930001A (en) 2002-01-21
CN1455813A (zh) 2003-11-12
NO20030019L (no) 2003-03-07
CA2415484A1 (en) 2002-01-17
IL153641A0 (en) 2003-07-06
DE60139694D1 (de) 2009-10-08
US7387873B2 (en) 2008-06-17
CN100497601C (zh) 2009-06-10
EP1299524B1 (en) 2009-08-26
NO20030019D0 (no) 2003-01-03
EP1299524A1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
KR100255717B1 (ko) 항체의 생산방법
JP3452062B2 (ja) Ｃｄｒ―移植された抗体
US9333255B2 (en) Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies
JP2022533621A (ja) 認識分子を含む操作された免疫細胞
CN103980361B (zh) 抗体
KR20120059659A (ko) Ｐａｎ-ｋｉｒ2ｄｌ ｎｋ-수용체 항체 및 진단 및 치료에서의 그 사용 방법
JPH0789909B2 (ja) ハイブリドーマセルラインの製造法
JP2002507398A (ja) ヒト・モノクローナル抗体およびそのための使用の開発
WO2021052307A1 (zh) 一种抗b7-h3抗体及其应用
KR20230166096A (ko) Cldn18.2 항원 결합 단백질 및 이의 적용
CN100497601C (zh) 人骨髓瘤细胞系
US20100015593A1 (en) Method for producing a composition for promoting survival of transplanted hematopoietic stem cell
AU2001269300A1 (en) Human myeloma cell line
EP2009094B1 (en) Fusion partner cells
US8859278B2 (en) Fully human hybridoma fusion partner cell lines
JP2004502454A5 (enExample)
Lindl Development of human monoclonal antibodies: A review
James Human monoclonal antibody technology
WO1989000607A1 (en) Preparation of human monoclonal antibodies of selected specificity and isotypes
EP2444484B1 (en) Method for producing antibodies using cancer cells
WO2022162009A1 (en) Method for rapid identification of cross-reactive and/or rare antibodies
WO2022161597A1 (en) Method for rapid identification of cross-reactive and/or rare antibodies
RU1801117C (ru) Способ получения монокло- нального антитела к моноклональному антителу к белку т4 лимфоцита человека, культивируемая клетка гибридомы jthfs-про- дуцентмоноклонального антитела к моноклональному антителу к белку т4 лимфоцита чело- века, культивируемая клетка гибридомы jti-if3-f5 - продуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцитачеловека, культивируемая клетка гибридомы jti-id7 - про- дуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцита человека, культивируемая клетка гибридомы jt2-n15 - продуцент моноклонального антитела к моноклональному антителу к белку т4 лимфоцитачеловека
JPH06327491A (ja) マウス細胞表面抗原に対するハムスターモノクローナル抗体
Smyrnis The generation of monoclonal antibodies to neural cell type-specific antigenic determinants

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080611

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100209